Free Trial

IPO Quiet Period Expirations

After a company issues an IPO, insiders and underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates on the company for a set period of time as a result of SEC regulations. This period of time is often referred to as a quiet period. Following the end of a company's quiet period, brokerages that served as underwriters often initiate research coverage on the company.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
Company NameCurrent PriceExpiration DateNumber of SharesInitial Share PriceOffer SizeDate PricedIndicator(s)
JATT III Acquisition Corp stock logo
JTTT
JATT III Acquisition
$10.55
+0.3%
10/5/20266,000,000$10.00$60,000,0008/26/2026
RNAQ
Rainier Acquisition
$10.03
+0.0%
10/6/20267,500,000$10.00$75,000,0008/27/2026
TLAC
Three Lions Acquisition
$9.86
+0.2%
10/12/202610,000,000$10.00$100,000,0009/1/2026
ETRA
Electra Therapeutics
$8.75
-2.1%
10/28/202623,333,334$15.00$350,000,0109/18/2026
Orion180 Insurance Group Inc. stock logo
OIG
Orion180 Insurance Group
$9.15
+1.0%
10/28/202620,000,000$12.00$240,000,0009/18/2026
ADRX
ADARx Pharmaceuticals
$17.70
-0.7%
11/4/202626,250,000$17.00$446,250,0009/25/2026
Accelevation Holdings Corp. stock logo
ACCV
Accelevation
$13.72
-2.7%
11/9/202630,000,000$18.00$540,000,0009/30/2026
CHWM
Chilwa Minerals
$5.14
-1.2%
11/10/2026625,000$5.60$3,500,00010/1/2026
RTSN
Retension Pharmaceuticals
$12.21
+4.9%
11/18/20263,750,000$12.00$45,000,00010/9/2026